Sign inGet started

CICIC DRAGAN

Insider CIK 1565795 · ATNM Chief Technology Officer · SLS SVP, Chief Development Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SLS SELLAS Life Sciences Group A Award2026-01-072026-01-09300,000— $0557,805SEC↗
SLS SELLAS Life Sciences Group J Other2025-12-032025-12-0563,800$1.50 $95.7K257,805SEC↗
SLS SELLAS Life Sciences Group A Award deriv2025-01-102025-01-14169,500— $0169,500SEC↗
SLS SELLAS Life Sciences Group A Award2025-01-102025-01-14113,000— $0228,328SEC↗
SLS SELLAS Life Sciences Group A Award2025-01-102025-01-1481,300— $0309,628SEC↗
SLS SELLAS Life Sciences Group J Other2024-12-042024-12-058,256$1.13 $9.3K115,328SEC↗
ATNM Actinium Pharmaceuticals, A Award deriv2017-03-142017-03-1675,000$1.39 $104.2K75,000SEC↗
ATNM Actinium Pharmaceuticals, A Award deriv2016-04-152016-04-1850,000$1.99 $99.5K50,000SEC↗
ATNM Actinium Pharmaceuticals, A Award deriv2015-05-072015-05-222,874$2.52 $7.2K2,874SEC↗
ATNM Actinium Pharmaceuticals, F Tax w/h2015-05-072015-05-22560$2.52 $1.4K560SEC↗
ATNM Actinium Pharmaceuticals, D To issuer2015-05-072015-05-222,380$2.52 $6.0K560SEC↗
ATNM Actinium Pharmaceuticals, A Award deriv2015-02-182015-03-1635,000$3.58 $125.3K35,000SEC↗
ATNM Actinium Pharmaceuticals, A Award deriv2014-02-212015-03-1631,500$5.55 $174.8K31,500SEC↗
ATNM Actinium Pharmaceuticals, A Award2014-02-212015-03-163,500$5.55 $19.4K3,500SEC↗